Cancer researchers gain valuable insights through a comprehensive review of Clioquinol

Researchers at Karmanos Cancer Institute of Wayne State University compiled the latest cancer research on clioquinol (CQ), an anti-fungal/anti-protozoal hydroxyquinoline family drug. The authors reported that although CQ isn’t suitable for cancer therapy currently, using CQ derivatives or analogues such as nitroxoline as well as combining CQ with other drugs, including docahexaenooic acid or disulfiram, are potential cancer treatments, as supported by strong positive preclinical results.